Paper Details

  1. Home
  2. Paper Details

Retrospective analysis of treatment outcome in 315 patients with oligodendroglial brain tumors.

Author: GrafE, NikkhahG, OstertagCb, TilgnerJ, TrippelM, VesperJ, WilleC

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Chemotherapy with procarbazine and lomustine (PC) may be as effective as procarbazine, lomustine, and vincristine (PCV) for oligodendroglial brain tumors, while avoiding the additional risks associated with vincristine.
Paper Details　
Original Abstract of the Article :
Although chemotherapy with procarbazine, lomustine and vincristine (PCV) is considered to be well tolerated, side effects frequently lead to dose reduction or even discontinuation of treatment of oligodendroglial brain tumors. The primary objective of the analysis was to retrospectively compare prog...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719586/

データ提供：米国国立医学図書館（NLM）

Treatment Outcomes in Oligodendroglial Brain Tumors

This study delves into the complex world of oligodendroglial brain tumors, investigating the effectiveness of different chemotherapy regimens in treating these challenging conditions. The researchers retrospectively analyzed data from patients with oligodendroglial tumors, comparing the outcomes of two chemotherapy regimens: PCV (procarbazine, lomustine, and vincristine) and PC (procarbazine and lomustine). The study reveals that PC chemotherapy may be as effective as PCV, but without the added risk of vincristine-related side effects. The findings highlight the importance of personalized treatment approaches tailored to individual patient needs and risk profiles.

Finding the Right Path for Oligodendroglial Tumor Treatment

This study is like a desert explorer carefully navigating a challenging terrain, seeking the most effective and safe route for treating oligodendroglial tumors. The findings suggest that PC chemotherapy offers a viable alternative to PCV, potentially reducing the risk of side effects while maintaining therapeutic efficacy. This study encourages a more personalized approach to treatment, tailoring therapies to the individual needs and characteristics of each patient.

Understanding Brain Tumor Treatment

If you are diagnosed with a brain tumor, it’s crucial to work closely with your healthcare team to develop a comprehensive treatment plan. They can guide you through the complexities of treatment options, ensuring you receive the best possible care tailored to your unique needs. Finding the right treatment path is like a camel seeking the most reliable water source in a vast desert; seeking guidance is essential.

Dr.Camel's Conclusion

This study offers valuable insights into the management of oligodendroglial brain tumors, emphasizing the importance of considering the potential risks and benefits of different chemotherapy regimens. It's a reminder that the desert of brain tumor research is vast and complex, requiring continuous investigation to refine treatment strategies and improve patient outcomes.

Date :
  1. Date Completed 2009-08-19
  2. Date Revised 2022-03-21
Further Info :

Pubmed ID

19604414

DOI: Digital Object Identifier

PMC2719586

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.